Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 4
2021 1
2023 4
2024 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Ketogenic diets for cognitive and behavioral function.
de la Rubia Ortí JE, García-Pardo MP, Cuerda-Ballester M, Castellano-Estornell G, Benlloch M. de la Rubia Ortí JE, et al. Among authors: cuerda ballester m. Front Nutr. 2024 Aug 7;11:1463796. doi: 10.3389/fnut.2024.1463796. eCollection 2024. Front Nutr. 2024. PMID: 39171115 Free PMC article. No abstract available.
Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review.
Caplliure-Llopis J, Peralta-Chamba T, Carrera-Juliá S, Cuerda-Ballester M, Drehmer-Rieger E, López-Rodriguez MM, de la Rubia Ortí JE. Caplliure-Llopis J, et al. Among authors: cuerda ballester m. Food Sci Nutr. 2019 Dec 16;8(1):23-35. doi: 10.1002/fsn3.1324. eCollection 2020 Jan. Food Sci Nutr. 2019. PMID: 31993129 Free PMC article. Review.
Lipid Profile in Multiple Sclerosis: Functional Capacity and Therapeutic Potential of Its Regulation after Intervention with Epigallocatechin Gallate and Coconut Oil.
de la Rubia Ortí JE, Platero Armero JL, Cuerda-Ballester M, Sanchis-Sanchis CE, Navarro-Illana E, Lajara-Romance JM, Benlloch M, Ceron JJ, Tvarijonaviciute A, Proaño B. de la Rubia Ortí JE, et al. Among authors: cuerda ballester m. Foods. 2023 Oct 11;12(20):3730. doi: 10.3390/foods12203730. Foods. 2023. PMID: 37893623 Free PMC article.
Predictive Model of Anxiety and Depression Perception in Multiple Sclerosis Patients: Possible Implications for Clinical Treatment.
Cuerda-Ballester M, Bustos A, Sancho-Cantus D, Martínez-Rubio D, Privado J, Alarcón-Jiménez J, Villarón-Casales C, de Bernardo N, Navarro Illana E, de la Rubia Ortí JE. Cuerda-Ballester M, et al. Bioengineering (Basel). 2024 Jan 22;11(1):100. doi: 10.3390/bioengineering11010100. Bioengineering (Basel). 2024. PMID: 38275580 Free PMC article.
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, de Bernardo N, AlarcÓn J, Fuente C, Carrera S, Sancho D, GarcÍa-Pardo P, Pascual R, JuÁrez M, Cuerda-Ballester M, Forner A, Sancho-Castillo S, Barrios C, Obrador E, Marchio P, Salvador R, Holmes HE, Dellinger RW, Guarente L, Estrela JM. de la Rubia JE, et al. Among authors: cuerda ballester m. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):115-122. doi: 10.1080/21678421.2018.1536152. Epub 2019 Jan 22. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30668199 Clinical Trial.
16 results